Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.
about
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseInflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical diseaseFibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's diseaseContribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's diseaseGenetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies'Alzheimer-like' pathology in a murine model of arterial hypertension.Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's diseaseAging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapyNew therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse modelIntravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology.Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse modelAmyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysisResorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.Alzheimer's disease: a clinical practice-oriented review.Cerebral microvascular rather than parenchymal amyloid-β protein pathology promotes early cognitive impairment in transgenic miceTRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Aβ.Hereditary cerebral hemorrhage with amyloidosis-Dutch type.CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects.Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluidA shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers.Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.Cerebral AL lambda-amyloidoma: clinical and pathomorphological characteristics. Review of the literature and of a patient.Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia.Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy.Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers.Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's diseaseThe "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease.Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer's disease.Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.Aquaporins and neurodegenerative diseases.Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease.
P2860
Q24631387-B1E61D15-DA76-4658-9566-059167FF6EC5Q27023953-0B6F640B-DF59-4249-A644-1223C06DAC12Q30495250-DA7CDBBC-A2FB-4D6C-86BA-8847A04ED061Q30623665-DE3941D2-BA5F-414E-B044-6C4EE6742A53Q33266027-B5D62A05-517A-4B3C-B719-654C36861D3EQ33747695-135DC6C8-D628-4952-8926-4400CCB31BBBQ33970434-DFBDE35B-6341-46B9-A800-07E83F200C38Q34149357-B04E97C2-5A25-4CEF-9322-69FAF0F52F72Q34209319-69D8D91B-0CEC-4F7F-8E4E-513028BE2DBEQ34219814-ECC422D1-2E5F-4537-8BD6-6257CBF3F8B9Q34368970-BF589332-D973-41B2-B130-80ABB1A7D094Q34375724-CEFAD553-CEC3-423F-8490-924881740BA4Q34465222-1BE3C269-1A36-468B-9A4C-8511CAA77530Q34738708-CB72EA08-B581-4F42-A85F-314AECDCC9D9Q35105958-0F1FEFD0-F48A-49B5-A86A-C10C7C821136Q35222076-77640331-3AF3-446B-B1C0-9CBB92EA62C5Q35674780-3565A63A-A5C5-4F9F-9FFB-76AFB7B97731Q35899503-10085660-26FE-4A93-850F-7FD3CA81A1EDQ36051548-BAE4575D-9DB3-43DD-965D-FC30B12CD3CDQ36071985-DB5B0796-1B63-4E4B-815F-B6026DAD09BCQ36355476-F94EA64B-95D8-400A-BB89-9BF4CF474E71Q36407301-ABCAB082-83D1-4AC7-91AA-EC08C2C1A563Q36448521-1E0CFAAA-5A3D-45DD-A08C-68BAA3D39D95Q36595017-C2D04B2A-55CB-4803-9501-8E309513564CQ36652260-13EA8741-C24D-4669-BD3C-CD788699FA0FQ36731538-61F96E89-057D-4224-92A2-7211C1ED02C3Q36786388-D493D020-4FEB-4846-B9CC-CBE0D79B5571Q36799367-55A959BC-9985-41AD-9ADF-4CF835F1D88EQ36985886-030732BD-90B9-42B2-94FE-0E904059EB6AQ37079075-A0AD2437-F71D-4DA3-8336-341A6A041F66Q37204006-C9CFB29C-9200-4510-9E64-1A78B14417A3Q37211285-2E669FD8-0D44-4354-A03E-5AB49A921269Q37236385-AD020A81-0EC4-472D-AA2C-0C14A28343EBQ37313963-162F3F6C-39BD-4744-9106-935326A08E86Q37543915-8111815A-0426-42F8-9CB2-DC07B6EC87FBQ37613107-77A3E1AB-90B8-4191-9523-4E38EDA3775EQ37623111-74C7F2CB-2BD9-4B91-9830-472A1F449AF0Q37670716-86E13997-62B3-4984-B139-6F65F34C93F9Q37814121-4680C809-F3C5-4E62-B774-C1DF3B2F1B17Q37957863-305EAA2B-0050-49F4-8CFF-2EFFA332D15B
P2860
Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cerebral amyloid angiopathy pl ...... e. Pro-CAA position statement.
@ast
Cerebral amyloid angiopathy pl ...... e. Pro-CAA position statement.
@en
type
label
Cerebral amyloid angiopathy pl ...... e. Pro-CAA position statement.
@ast
Cerebral amyloid angiopathy pl ...... e. Pro-CAA position statement.
@en
prefLabel
Cerebral amyloid angiopathy pl ...... e. Pro-CAA position statement.
@ast
Cerebral amyloid angiopathy pl ...... e. Pro-CAA position statement.
@en
P2093
P1476
Cerebral amyloid angiopathy pl ...... se. Pro-CAA position statement
@en
P2093
Bozena Mazur-Kolecka
Janusz Frackowiak
Masahito Yamada
Roy O Weller
P304
589-97; discussion 603-4
P356
10.1016/J.NEUROBIOLAGING.2004.02.003
P577
2004-05-01T00:00:00Z